Conditions: Renal Transplant
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 173
Healthy volunteers: no

Brief summary:
The purpose of this study is to learn if conversion to belatacept from cyclosporine or tacrolimus will preserve kidney function in people who have had a kidney transplant. The safety and tolerability of this treatment will also be studied

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Belatacept intervention 2: Cyclosporine A intervention 3: Tacrolimus
Intervention descriptions: intervention 1: IV, IV Infusion, 5 mg/kg once every 28 days for one year intervention 2: Tablets, Oral, Trough of 100-250 ng/mL, 2\* daily for one year intervention 3: Tablets, Oral, Trough of 5-10 ng/mL, 2\* daily for one year

Protocol document: